BeiGene launches IPO on Shanghai’s STAR market to raise $3B
BeiGene Ltd announces the third round of its initial public offering (IPO) on the STAR market of Shanghai Stock Exchange to raise US $3.5 billion. The global biotech company, based in Beijing, China offers around 115 million ordinary shares, representing 8.62% of its total outstanding shares.
GO Prime with only $1.49 now
LATEST
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115